UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 10, 2003
RIBAPHARM INC.
(Exact name of registrant as specified in charter)
| Delaware (State or other jurisdiction of incorporation) |
1-31294 (Commission File Number) |
95-4805655 (I.R.S. Employer Identification No.) |
3300 Hyland Avenue, Costa Mesa, CA 92626
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (714) 427-6236
Item 5. Other Events and Required FD Disclosure.
The Registrant hereby incorporates by reference the contents of the press release of the Registrant, dated June 10, 2003, filed herewith as Exhibit 99.1.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
| 99.1 | Press Release of the Company dated June 10, 2003. | |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| RIBAPHARM INC. | ||||||||
| Date: June 10, 2003 | By: | /s/ KIM D. LAMON | ||||||
| Kim D. Lamon President and Chief Executive Officer | ||||||||
3
EXHIBIT INDEX
| 99.1 | Press Release of the Company dated June 10, 2003. | |
4